Andrew B Koo, Lily Zhou, Irbaz Hameed, Cyprien A Rivier, Santiago Clocchiatti-Tuozzo, Hooman Kamel, Guido J Falcone, John Ney, Richa Sharma, Charles Matouk, Shadi Yaghi, Kevin Navin Sheth, Adam de Havenon
{"title":"Acute Ischemic Stroke Risk Following Cardiac Interventions in the United States From 2016 to 2021.","authors":"Andrew B Koo, Lily Zhou, Irbaz Hameed, Cyprien A Rivier, Santiago Clocchiatti-Tuozzo, Hooman Kamel, Guido J Falcone, John Ney, Richa Sharma, Charles Matouk, Shadi Yaghi, Kevin Navin Sheth, Adam de Havenon","doi":"10.1212/WNL.0000000000213766","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Ischemic stroke following cardiac intervention is a serious complication. However, there are limited data comparing stroke risk and severity among patients undergoing different types of cardiac interventions. We examined the incidence of ischemic stroke among patients undergoing cardiac interventions and identified variables associated with risk and severity of ischemic stroke.</p><p><strong>Methods: </strong>We included cardiac intervention hospitalizations for adults within the United States from 2016 to 2021 in the National Inpatient Sample. We constructed a cross-sectional cohort of cardiac intervention hospitalizations comprising all hospitalizations within a Centers for Medicare & Medicaid Services-defined \"Cardiac Surgery\" Diagnosis-Related Group. The exposure was category of cardiac intervention, and primary outcome was ischemic stroke in any coding position. After survey weighting, we examined the frequency and factors associated with ischemic stroke, stroke severity, and inpatient mortality. A secondary analysis was performed in a subset of patients with documented NIH Stroke Scale (NIHSS).</p><p><strong>Results: </strong>After survey weighting, among 6,083,899 cardiac intervention hospitalizations (mean age: 67.8 years, 34.5% female), ischemic stroke was diagnosed in 75,280 (1.24%). A higher risk of stroke was associated with female sex (vs male, adjusted odds ratio [OR] 1.25, 95% CI 1.20-1.29), age 75 or older (vs 18-54, OR 1.33, 95% CI 1.23-1.42), and non-Hispanic Black ethnicity (vs White, OR 1.32, 95% CI 1.24-1.39). Compared with percutaneous interventions, open cardiac surgery was associated with higher incidence of stroke (adjusted OR 2.47, 95% CI 2.39-2.55) and the strokes were significantly more severe (NIHSS median: 5 vs 3, mean 8.7 vs 5.6, respectively, <i>p</i> < 0.001). Among patients undergoing a cardiac intervention, the rate of ischemic stroke increased from 1.10% in 2016 to 1.33% in 2021 (<i>p</i> < 0.001) and ischemic stroke increased the risk of in-hospital death 5-fold (OR 5.07, 95% CI 4.77-5.39).</p><p><strong>Discussion: </strong>Ischemic stroke during hospitalizations for cardiac interventions in the United States varies by type of intervention and shows an increasing trend from 2016 to 2021. Cardiac intervention patients sustaining an ischemic stroke are 5 times as likely to have in-hospital death as those without stroke. Further research is needed to identify high-risk populations that could benefit from specific postoperative monitoring strategies and/or specific therapeutic interventions.</p>","PeriodicalId":19256,"journal":{"name":"Neurology","volume":"105 1","pages":"e213766"},"PeriodicalIF":7.7000,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12165311/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1212/WNL.0000000000213766","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/10 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objectives: Ischemic stroke following cardiac intervention is a serious complication. However, there are limited data comparing stroke risk and severity among patients undergoing different types of cardiac interventions. We examined the incidence of ischemic stroke among patients undergoing cardiac interventions and identified variables associated with risk and severity of ischemic stroke.
Methods: We included cardiac intervention hospitalizations for adults within the United States from 2016 to 2021 in the National Inpatient Sample. We constructed a cross-sectional cohort of cardiac intervention hospitalizations comprising all hospitalizations within a Centers for Medicare & Medicaid Services-defined "Cardiac Surgery" Diagnosis-Related Group. The exposure was category of cardiac intervention, and primary outcome was ischemic stroke in any coding position. After survey weighting, we examined the frequency and factors associated with ischemic stroke, stroke severity, and inpatient mortality. A secondary analysis was performed in a subset of patients with documented NIH Stroke Scale (NIHSS).
Results: After survey weighting, among 6,083,899 cardiac intervention hospitalizations (mean age: 67.8 years, 34.5% female), ischemic stroke was diagnosed in 75,280 (1.24%). A higher risk of stroke was associated with female sex (vs male, adjusted odds ratio [OR] 1.25, 95% CI 1.20-1.29), age 75 or older (vs 18-54, OR 1.33, 95% CI 1.23-1.42), and non-Hispanic Black ethnicity (vs White, OR 1.32, 95% CI 1.24-1.39). Compared with percutaneous interventions, open cardiac surgery was associated with higher incidence of stroke (adjusted OR 2.47, 95% CI 2.39-2.55) and the strokes were significantly more severe (NIHSS median: 5 vs 3, mean 8.7 vs 5.6, respectively, p < 0.001). Among patients undergoing a cardiac intervention, the rate of ischemic stroke increased from 1.10% in 2016 to 1.33% in 2021 (p < 0.001) and ischemic stroke increased the risk of in-hospital death 5-fold (OR 5.07, 95% CI 4.77-5.39).
Discussion: Ischemic stroke during hospitalizations for cardiac interventions in the United States varies by type of intervention and shows an increasing trend from 2016 to 2021. Cardiac intervention patients sustaining an ischemic stroke are 5 times as likely to have in-hospital death as those without stroke. Further research is needed to identify high-risk populations that could benefit from specific postoperative monitoring strategies and/or specific therapeutic interventions.
背景与目的:心脏介入治疗后缺血性卒中是一种严重的并发症。然而,比较接受不同类型心脏干预的患者中风风险和严重程度的数据有限。我们检查了接受心脏干预的患者中缺血性卒中的发生率,并确定了与缺血性卒中风险和严重程度相关的变量。方法:我们在全国住院患者样本中纳入了2016年至2021年美国成人心脏干预住院。我们构建了一个心脏介入治疗住院的横断面队列,包括医疗保险和医疗补助服务中心定义的“心脏手术”诊断相关组内的所有住院病例。暴露是心脏干预的类别,主要结局是任何编码位置的缺血性卒中。在调查加权后,我们检查了与缺血性卒中、卒中严重程度和住院患者死亡率相关的频率和因素。在一组有NIH卒中量表(NIHSS)记录的患者中进行了二次分析。结果:经调查加权后,在6083899例心脏介入治疗住院患者(平均年龄67.8岁,女性34.5%)中,诊断为缺血性脑卒中的有75280例(1.24%)。较高的卒中风险与女性(相对于男性,校正优势比[OR] 1.25, 95% CI 1.20-1.29)、75岁及以上(相对于18-54岁,OR 1.33, 95% CI 1.23-1.42)和非西班牙裔黑人(相对于白人,OR 1.32, 95% CI 1.24-1.39)相关。与经皮介入治疗相比,心内直视手术与更高的卒中发生率相关(校正OR 2.47, 95% CI 2.39-2.55),卒中明显更严重(NIHSS中位数:5 vs 3,平均值8.7 vs 5.6, p < 0.001)。在接受心脏干预的患者中,缺血性卒中的发生率从2016年的1.10%增加到2021年的1.33% (p < 0.001),缺血性卒中使院内死亡风险增加了5倍(OR 5.07, 95% CI 4.77-5.39)。讨论:在美国,因心脏干预而住院期间的缺血性卒中因干预类型而异,2016年至2021年呈上升趋势。心脏介入治疗的缺血性中风患者住院死亡的可能性是没有中风的患者的5倍。需要进一步的研究来确定高危人群,这些人群可以从特定的术后监测策略和/或特定的治疗干预中受益。
期刊介绍:
Neurology, the official journal of the American Academy of Neurology, aspires to be the premier peer-reviewed journal for clinical neurology research. Its mission is to publish exceptional peer-reviewed original research articles, editorials, and reviews to improve patient care, education, clinical research, and professionalism in neurology.
As the leading clinical neurology journal worldwide, Neurology targets physicians specializing in nervous system diseases and conditions. It aims to advance the field by presenting new basic and clinical research that influences neurological practice. The journal is a leading source of cutting-edge, peer-reviewed information for the neurology community worldwide. Editorial content includes Research, Clinical/Scientific Notes, Views, Historical Neurology, NeuroImages, Humanities, Letters, and position papers from the American Academy of Neurology. The online version is considered the definitive version, encompassing all available content.
Neurology is indexed in prestigious databases such as MEDLINE/PubMed, Embase, Scopus, Biological Abstracts®, PsycINFO®, Current Contents®, Web of Science®, CrossRef, and Google Scholar.